⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7990751 | 1.00 | — | — | |
| SCHEMBL7986968 | 0.94 | — | — | |
| SCHEMBL6741681 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL6741941 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL30949390 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL6741902 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL6740673 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL2268490 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL6740679 | 0.91 | LMNA (0.32) | — | |
| SCHEMBL6740962 | 0.91 | LMNA (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6288066-B1 | ANTIDIABETIC AGENTS; OXIDATION, HYDROLYSIS | AVENTIS PHARMA S.A. (FR) | 2001-09-11 | — | — | US | claimed |
| US-6288066-B1 | ANTIDIABETIC AGENTS; OXIDATION, HYDROLYSIS | AVENTIS PHARMA S.A. (FR) | 2001-09-11 | — | — | US | disclosed |